79 related articles for article (PubMed ID: 9066701)
1. Immunohistochemical detection of p53 protein overexpression in primary human osteosarcomas.
Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):493-8. PubMed ID: 9066701
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression.
Bodey B; Taylor CR; Siegel SE; Kaiser HE
Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
Turner BC; Gumbs AA; Carbone CJ; Carter D; Glazer PM; Haffty BG
Cancer; 2000 Mar; 88(5):1091-8. PubMed ID: 10699900
[TBL] [Abstract][Full Text] [Related]
5. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
6. Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Terada T; Shimizu K; Izumi R; Nakanuma Y
Mod Pathol; 1994 Feb; 7(2):249-52. PubMed ID: 8008749
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas.
Bodey B; Bodey B; Kaiser HE
Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas.
Bernardini S; Adessi GL; Billerey C; Chezy E; Carbillet JP; Bittard H
J Urol; 1999 Oct; 162(4):1496-501. PubMed ID: 10492244
[TBL] [Abstract][Full Text] [Related]
10. A microwave method that enhances detection of aberrant p53 expression in formalin-fixed, paraffin-embedded tissues.
Resnick JM; Cherwitz D; Knapp D; Uhlman D; Niehans GA
Arch Pathol Lab Med; 1995 Apr; 119(4):360-6. PubMed ID: 7726729
[TBL] [Abstract][Full Text] [Related]
11. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of Ets-1 and p53 in oral carcinomas is associated with P-glycoprotein expression and poor prognosis.
Soni S; Pande P; Shukla NK; Ralhan R
J Cancer Res Clin Oncol; 2002 Jun; 128(6):336-42. PubMed ID: 12073053
[TBL] [Abstract][Full Text] [Related]
13. p53 protein immunostaining in routinely processed paraffin-embedded sections.
Bruner JM; Connelly JH; Saya H
Mod Pathol; 1993 Mar; 6(2):189-94. PubMed ID: 8483890
[TBL] [Abstract][Full Text] [Related]
14. Correlation between p53 expression and other prognostic factors in breast cancer.
Roşianu A; Tudose N
Rom J Morphol Embryol; 1998; 44(1-4):133-40. PubMed ID: 15678854
[TBL] [Abstract][Full Text] [Related]
15. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.
Lambkin HA; Mothersill CM; Kelehan P
J Pathol; 1994 Jan; 172(1):13-8. PubMed ID: 7931822
[TBL] [Abstract][Full Text] [Related]
16. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
17. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
18. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance.
Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE
Anticancer Res; 1997; 17(2B):1311-8. PubMed ID: 9137491
[TBL] [Abstract][Full Text] [Related]
20. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
